Diseases, Conditions, Syndromes

Anti-inflammatory drug may shorten COVID-19 recovery time

A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized COVID-19 patients shortens their time to recovery by an additional day.

Diseases, Conditions, Syndromes

COVID hits young adults harder than thought: study

New research suggests that COVID-19 is far from benign when it strikes young adults: Once they are hospitalized, 1 in 5 wind up in the ICU and many need ongoing medical care even after they are free of the virus, scientists ...

Diseases, Conditions, Syndromes

Computer models for 80 potential COVID-19 treatments

Australian scientists using cloud-based supercomputer programs have joined forces with biotechnology company Vaxine Pty Ltd to identify up to 80 new potential candidate drugs against the COVID-19 virus.

Diseases, Conditions, Syndromes

Polish miners' blood boosts search for new COVID-19 drug

Blood donations from Polish coal miners who recovered from coronavirus have helped research into a new plasma-derived drug, researchers said on Tuesday, as they announced the start of production and testing in Poland.

Medications

Old drug standards delay new drug approvals

During the next year, the Food and Drug Administration will review many new drug applications for preventing and treating the new coronavirus. But early approvals could get delayed by the standards the agency used for older ...

page 26 from 40